14.28 +0.01 (0.07%)
LGND
| Trade LGND now with |
Stock Details
Last Trade:14.28 Change:+0.01 (0.07%) Prev Close:14.27 Open: 14.26 Days Range:14.05 – 14.39 52 Week Range: 8.98 - 16.24 Volume:35313 P/E: 40.80EPS:0.35
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 4:49pm
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q4 EPS of $0.24, versus $0.12 reported last year. Revenue for the quarter came in at $12.9 million, versus $3.9 million reported last year. For 2012, Ligand currently estimates total revenues... Read More
Recent Alert on 02/07/12 at 4:49pm
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 Earnings of $0.24, Offers FY12 Sales Guidance
Recent Alert on 02/06/12 at 5:24pm
Trading Radar for 02/07: Coca-Cola (KO), Disney (DIS), BP plc (BP), Open Table (OPEN), Lannett (LCI) Report
Trading Radar for 02/07: Coca-Cola (KO), Disney (DIS), BP plc (BP), Open Table (OPEN), Lannett (LCI) Report
Recent Alert on 02/02/12 at 6:47am
Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
Recent Alert on 02/02/12 at 6:47am
Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
Ligand Pharma (LGND) Completes PG-Free Melphalan Phase II, Issues Update
View AllRecent Press Releases
Press Release on 02/07/12 at 4:05pm
Ligand Reports Fourth Quarter and Full Year 2011 Financial Results
Ligand Reports Fourth Quarter and Full Year 2011 Financial Results
Press Release on 02/07/12 at 8:00am
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 12/23/11 at 8:14am
Insiders And Hedge Fund Star Dan Loeb Are Bullish About These Stocks
Insiders And Hedge Fund Star Dan Loeb Are Bullish About These Stocks
Blog Posts on 11/02/11 at 7:18am
Ligand Pharmaceuticals' Insider Buys Continue Ahead Of New Catalysts
Ligand Pharmaceuticals' Insider Buys Continue Ahead Of New Catalysts


